The recent Myriad U.S. Supreme Court decision has limited the patentability of biotechnology and life sciences inventions. In light of the Myriad decision, the USPTO has institute...
READ MOREtraverselegal - September 22, 2014 - Patent
The recent Myriad U.S. Supreme Court decision has limited the patentability of biotechnology and life sciences inventions. In light of the Myriad decision, the USPTO has institute...
READ MORE